Join the Migraine group to help and get support from people like you.
Migraine News
Related terms: Migraine Headache, Hemiplegic Migraine, Complicated Migraine, Basilar-Type Migraine, Basilar Artery Migraine
Understanding Headaches: Types, Triggers And New Treatments
SUNDAY, Sept. 14, 2025 — Everyone gets headaches, but not all headaches are the same. For some, they’re a quick inconvenience. For others, they can be intense, long-lasting and even disabling, disr...
Understanding Headaches: Types, Triggers And New Treatments
SUNDAY, Sept. 14, 2025 — Everyone gets headaches, but not all headaches are the same. For some, they’re a quick inconvenience. For others, they can be intense, long-lasting and even disabling, disr...
Video Head Impulse Test, Caloric Test Can Differentiate Meniere Disease, Vestibular Migraine
FRIDAY, Sept. 12, 2025 – The video head impulse test (vHIT) and caloric test can help differentiate Meniere disease (MD) from vestibular migraine (VM), according to a study published online Aug. 6...
FDA Approves Ajovy for Migraine Prevention in Children and Teens
MONDAY, Aug. 11, 2025 – The U.S. Food and Drug Administration has approved the single-dose Ajovy (fremanezumab-vfrm) injection for the preventive treatment of episodic migraine in children and...
FDA Approves Expanded Indication for Ajovy (fremanezumab-vfrm), the First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine
PARSIPPANY, N.J. and TEL AVIV, Israel, Aug. 06, 2025 (GLOBE NEWSWIRE) – Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today that the...
Liraglutide May Reduce Migraine Burden in Adults With Obesity, Migraine
MONDAY, June 30, 2025 – For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and Migraine Disability Assessment (MIDAS) scores,...
Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
MONDAY, June 23, 2025 – The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately diagnoses Meniere disease...
Endolymphatic Sac Decompression Effective for Vertigo, Migraine
WEDNESDAY, May 28, 2025 – For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and migraine, according to a...
FDA Approves Brekiya (dihydroergotamine mesylate) Injection for the Acute Treatment of Migraine and Cluster Headaches in Adults
BRIDGEWATER, N.J., May 15, 2025 – Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved Brekiya (dihydr...
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
WEDNESDAY, May 21, 2025 – Children prenatally exposed to different triptan intensities and duration, alone or in combination with other preventive medications for migraine, do not have increased...
Battling Multiple Chronic Illnesses Can Double Risk Of Depression
WEDNESDAY, May 21, 2025 — Battling chronic disease really takes it out of a person, leaving them vulnerable to depression. And people with multiple long-term health problems are even more likely to f...
Oral Health Linked To Migraines, Fibromyalgia
TUESDAY, May 20, 2025 — Women who don’t brush and floss frequently are more likely to suffer from migraines and fibromyalgia, a new study says. Women with the worst oral health have a 60% higher risk ...
Ubrogepant (Ubrelvy) Effective Against Early Migraine Symptoms
WEDNESDAY, May 14, 2025 – Migraines don’t just cause headaches. These attacks often are accompanied by symptoms like light and sound sensitivity, nausea, neck pain and dizziness. What’s more, those n...
Ubrogepant During Prodromal Phase of Migraine Eases Symptoms
TUESDAY, May 13, 2025 – Ubrogepant during the prodromal phase of migraine may alleviate common prodromal symptoms, according to a study published online May 12 in Nature Medicine. Peter J. Goadsby,...
FDA Approves Atzumi (dihydroergotamine) Nasal Powder for the Acute Treatment of Migraine
DURHAM, N.C., April 30, 2025 /PRNewswire/ – Satsuma Pharmaceuticals, Inc., a late-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other...
Further information
Related condition support groups
Migraine Prevention, Migraine Prophylaxis, Chronic Migraine, Headache
Related drug support groups
gabapentin, ibuprofen, amitriptyline, venlafaxine, propranolol, diclofenac, cyclobenzaprine, topiramate, Botox, view more... sumatriptan, Excedrin, Imitrex, Ubrelvy, Excedrin Migraine, erenumab, cyproheptadine, verapamil, Reglan, Migraine Relief, Nurtec ODT